Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 0 | 0 | 2,991 | 0 | 0 |
| Operating Income | N/A | N/A | -2,991 | N/A | N/A |
| Other Income | 0 | 0 | 67 | 0 | 0 |
| Pre-tax Income | 0 | 0 | -2,924 | 0 | 0 |
| Net Income Continuous | N/A | N/A | -2,924 | N/A | N/A |
| Net Income | $N/A | $N/A | $-2,924 | $N/A | $N/A |
| EPS Basic Total Ops | N/A | N/A | -0.25 | N/A | N/A |
| EPS Basic Continuous Ops | N/A | N/A | -0.25 | N/A | N/A |
| EPS Diluted Total Ops | N/A | N/A | -0.25 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | -0.25 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 0.10 | -0.44 | -0.33 | -0.27 | -0.25 |
| EBITDA(a) | $N/A | $N/A | $-2,991 | $N/A | $N/A |